Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2008 | 09-2008 | 06-2008 | 03-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,110 | 2,450 | 5,670 | 4,040 | 5,130 |
| Marketable Securities | 2,500 | 2,450 | 500 | 500 | 500 |
| Other current assets | 830 | 790 | 180 | 60 | 50 |
| TOTAL | $4,440 | $5,690 | $6,350 | $4,600 | $5,680 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 4,357 | 4,297 | 4,267 | 3,757 | 3,637 |
| TOTAL | $4,357 | $4,297 | $4,267 | $3,757 | $3,637 |
| Total Assets | $8,810 | $10,000 | $10,640 | $8,380 | $9,340 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 460 | 500 | 370 | 160 | 550 |
| Accrued Expenses | 410 | 380 | 310 | 510 | 360 |
| Other current liabilities | 0 | 0 | 0 | 0 | 4 |
| TOTAL | $880 | $880 | $680 | $670 | $920 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 111 | 120 | 120 | 930 | 370 |
| TOTAL | $111 | $120 | $120 | $930 | $370 |
| Total Liabilities | $1,000 | $1,000 | $800 | $1,620 | $1,300 |
| Shareholders' Equity | |||||
| Common Shares | 190 | 180 | 180 | 170 | 170 |
| Retained earnings | -33,020 | -31,400 | -30,220 | -29,340 | -27,290 |
| Other shareholders' equity | -10 | 0 | 0 | 10 | -10 |
| TOTAL | $7,810 | $8,990 | $9,830 | $6,760 | $8,030 |
| Total Liabilities And Equity | $8,810 | $9,990 | $10,630 | $8,380 | $9,330 |